No products in the cart.
Return To ShopNo products in the cart.
Return To ShopNo products in the cart.
Return To Shopanabolicdirectplus.com
No products in the cart.
Return To ShopStenabolic (SR9009) 50 mg NovoSarm stands out in the competitive landscape of performance enhancement. As a synthetic drug and Rev-ErbA ligand, it has gained traction for its unique mechanism of action, differing significantly from traditional anabolic agents. With a focus on increasing mitochondrial count and enhancing endurance, this product has positioned itself as a game changer for athletes and fitness enthusiasts alike. Its formulation promises not only to help users achieve their fitness goals but also to do so with minimal side effects, making it an attractive alternative to more conventional options.
The benefits of Stenabolic (SR9009) extend well beyond mere muscle gain. Users can experience a remarkable increase in endurance, significant fat mass reduction, and heightened wakefulness. This combination makes it ideal for those looking to optimize their athletic performance or enhance their gym workouts. Here are a few competitive advantages that set it apart:
Stenabolic (SR9009) 50 mg NovoSarm is tailored for a diverse audience, including athletes, bodybuilders, and fitness enthusiasts aiming to elevate their physical performance. It is particularly suited for those engaged in endurance sports or high-intensity training regimes, where stamina and quick recovery matter most. Additionally, it can be beneficial for individuals looking to shed excess fat while maintaining muscle mass. As always, understanding personal health conditions is essential, and consulting a healthcare professional before use is advisable to ensure a safe experience.
| Active substance | SARMs |
|---|---|
| Water Retention | No significant water retention |
| Hepatotoxicity | Not enough data to determine |
| Lab Test | Specific tests for detection in blood or urine not widely detailed |
| Also known as | SR9009, Stenabolic |
| Blood pressure | No significant impact reported |
| Trade name | Not available under any trade name as it is not commercially marketed |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate |
| Formula | C20H24ClN3O4S |
| Substance class | Synthetic drug, Rev-ErbA ligand |
| Main action | Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage |
| Half-life | Approximately 4-5 hours |
| Dosage (medical) | Not clinically approved for medical use |
| Dosage (sports) | Typically 10-40 mg per day |
| Effects | Increased endurance, reduced fat mass, increased wakefulness |
| Side effects | Potential alterations in circadian rhythms, limited data on long-term effects |
| Use in sports | Used as a performance-enhancing drug, not approved by WADA |
| Active ingredient, mg | 50 |
| Release form | Vial |
| 1 Vial, ml | 10 |
| Vials in the package, pcs | 1 |
| Manufacturer | NovoSarm |
Select at least 2 products
to compare
Reviews
There are no reviews yet.